BRIEF-Vanda Pharmaceuticals Q3 EPS USD -0.38

Reuters
Oct 30
BRIEF-Vanda Pharmaceuticals Q3 EPS USD -0.38

Oct 29 (Reuters) - Vanda Pharmaceuticals Q3 operating income USD -31.284 million.

  • Q3 net income USD -22.586 million
  • Q3 basic EPS USD -0.38
  • Q3 operating expenses USD 87.542 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10